Prostarm Info Systems revises commercial production timeline to Sep 30, 2026
Prostarm Info Systems Ltd has postponed the start of commercial production at its Haryana and Gujarat manufacturing facilities to September 30, 2026, due to external and geopolitical factors affecting resource availability. The company confirmed that construction of the factory buildings is substantially complete and is working to expedite the procurement process.

*this image is generated using AI for illustrative purposes only.
Prostarm Info Systems has revised the timeline for commencing commercial production at its proposed manufacturing facilities to September 30, 2026. The company cited unavoidable circumstances, including external factors and prevailing geopolitical conditions, as reasons for the delay impacting the timely availability of required resources.
The facilities in question include a 1.2 GWh Battery Energy Storage System (BESS) Manufacturing Facility at Reliance MET, Jhajjar, Haryana, and a manufacturing facility at Bakrol, Gujarat. Prostarm Info Systems disclosed that the factory buildings for both facilities are substantially ready, despite the operational delay.
In a regulatory filing, the company referenced earlier intimations dated July 08, 2025, and December 30, 2025, regarding the establishment of these facilities. The revised schedule was communicated to BSE Limited and National Stock Exchange of India Limited under Regulation 30 of the SEBI Listing Regulations.
Prostarm Info Systems affirmed that it continues to monitor the situation closely and is taking necessary steps to expedite procurement. The company aims to commence commercial production at the earliest within the new timeline.
| Facility Details | Location |
|---|---|
| 1.2 GWh BESS Manufacturing Facility | Reliance MET, Jhajjar, Haryana |
| Manufacturing Facility | Bakrol, Gujarat |
Historical Stock Returns for Prostarm Info Systems
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.06% | -1.70% | -9.07% | -18.08% | -43.12% | -1.39% |
What specific financial provisions or cost overruns does Prostarm anticipate due to this 18-month delay?
How will the postponed production start date affect Prostarm's ability to secure long-term purchase agreements for its BESS products?
Could the delay impact the company's eligibility for government subsidies or incentives tied to manufacturing commencement deadlines?


































